{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:20:11Z","timestamp":1792070411020,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1053\/j.semperi.2013.01.009","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T01:43:04Z","timestamp":1365558184000},"page":"124-131","source":"Crossref","is-referenced-by-count":157,"title":["Pulmonary hypertension in bronchopulmonary dysplasia"],"prefix":"10.1053","volume":"37","author":[{"given":"Sara K.","family":"Berkelhamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K.","family":"Mestan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin H.","family":"Steinhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.siny.2009.08.004","article-title":"Long-term outcomes of bronchopulmonary dysplasia","volume":"14","author":"Doyle","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"issue":"4","key":"10.1053\/j.semperi.2013.01.009_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.semperi.2006.05.010","article-title":"Neurodevelopmental outcome of bronchopulmonary dysplasia","volume":"30","author":"Anderson","year":"2006","journal-title":"Semin Perinatol"},{"issue":"11","key":"10.1053\/j.semperi.2013.01.009_bib3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archpedi.161.11.1082","article-title":"Developmental sequelae in preterm infants having a diagnosis of bronchopulmonary dysplasia: analysis using a severity-based classification system","volume":"161","author":"Short","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1378\/chest.11-1306","article-title":"General and respiratory health outcomes in adult survivors of bronchopulmonary dysplasia: a systematic review","volume":"141","author":"Gough","year":"2012","journal-title":"Chest"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MOP.0b013e3283464a52","article-title":"Recent progress in understanding pediatric pulmonary hypertension","volume":"23","author":"Abman","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"10.1053\/j.semperi.2013.01.009_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/jp.2010.213","article-title":"Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation","volume":"31","author":"Slaughter","year":"2011","journal-title":"J Perinatol"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4070\/kcj.2010.40.3.131","article-title":"Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia","volume":"40","author":"An","year":"2010","journal-title":"Korean Circ J"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000327891","article-title":"Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia","volume":"101","author":"Kim","year":"2012","journal-title":"Neonatology"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.2007-0971","article-title":"Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era","volume":"120","author":"Khemani","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib10","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1542\/peds.2011-1827","article-title":"Prospective analysis of pulmonary hypertension in extremely low birth weight infants","volume":"129","author":"Bhat","year":"2012","journal-title":"Pediatrics"},{"issue":"11","key":"10.1053\/j.semperi.2013.01.009_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ppul.22609","article-title":"Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia","volume":"47","author":"Collaco","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.prrv.2010.05.001","article-title":"Pulmonary hypertension in chronic neonatal lung disease","volume":"11","author":"Farquhar","year":"2010","journal-title":"Paediatr Respir Rev"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOP.0b013e3283423e6b","article-title":"The new bronchopulmonary dysplasia","volume":"23","author":"Jobe","year":"2011","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1542\/peds.75.1.80","article-title":"Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia","volume":"75","author":"Abman","year":"1985","journal-title":"Pediatrics"},{"issue":"9","key":"10.1053\/j.semperi.2013.01.009_bib15","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/rccm.200310-1483OC","article-title":"Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia","volume":"170","author":"Mourani","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib16","doi-asserted-by":"crossref","first-page":"L600","DOI":"10.1152\/ajplung.2000.279.3.L600","article-title":"Inhibition of angiogenesis decreases alveolarization in the developing rat lung","volume":"279","author":"Jakkula","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib17","doi-asserted-by":"crossref","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","article-title":"Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure","volume":"283","author":"Le Cras","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1053\/j.semperi.2013.01.009_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ppedcard.2009.09.007","article-title":"Pulmonary hypertension in bronchopulmonary dysplasia","volume":"27","author":"Mourani","year":"2009","journal-title":"Progr Pediatr Cardiol"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ppul.1950090306","article-title":"Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease","volume":"9","author":"Hislop","year":"1990","journal-title":"Pediatr Pulmonol"},{"key":"10.1053\/j.semperi.2013.01.009_bib20","doi-asserted-by":"crossref","unstructured":"Check J, Gotteiner N, Liu X, et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol advance online publication, January 17, 2013; doi:10.1038\/jp.2012.164,PMID: 23328924","DOI":"10.1038\/jp.2012.164"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib21","doi-asserted-by":"crossref","first-page":"L860","DOI":"10.1152\/ajplung.00197.2011","article-title":"Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep","volume":"301","author":"Rozance","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"10.1053\/j.semperi.2013.01.009_bib22","doi-asserted-by":"crossref","first-page":"L1011","DOI":"10.1152\/ajplung.2001.281.4.L1011","article-title":"Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs","volume":"281","author":"MacRitchie","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib23","doi-asserted-by":"crossref","first-page":"L749","DOI":"10.1152\/ajplung.00334.2002","article-title":"Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease","volume":"284","author":"Afshar","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib24","doi-asserted-by":"crossref","first-page":"L76","DOI":"10.1152\/ajplung.00395.2002","article-title":"Pulmonary vascular dysfunction in preterm lambs with chronic lung disease","volume":"285","author":"Bland","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/CIRCRESAHA.107.161463","article-title":"Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells","volume":"102","author":"Farrow","year":"2008","journal-title":"Circ Res"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2011.4184","article-title":"Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells","volume":"17","author":"Farrow","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1053\/j.semperi.2013.01.009_bib27","doi-asserted-by":"crossref","unstructured":"Farrow KN, Steinhorn RH. Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension. Handb Exp Pharmacol. 2011(204):251\u2013277","DOI":"10.1007\/978-3-642-17969-3_11"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1542\/peds.2005-2985","article-title":"Electrocardiography in the diagnosis of right ventricular hypertrophy in children","volume":"118","author":"Puchalski","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/peds.2007-1583","article-title":"Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease","volume":"121","author":"Mourani","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib31","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.1542\/peds.2008-0075","article-title":"Pulmonary vein stenosis: prematurity and associated conditions","volume":"122","author":"Drossner","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/bja\/aem059","article-title":"Risk of cardiac catheterization under anaesthesia in children with pulmonary hypertension","volume":"98","author":"Taylor","year":"2007","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ccd.22693","article-title":"Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the magic registry","volume":"76","author":"Hill","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1053\/j.semperi.2013.01.009_bib35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.amjcard.2011.07.025","article-title":"Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension","volume":"108","author":"Mauritz","year":"2011","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpeds.2011.06.038","article-title":"B-type natriuretic peptide and rebound during treatment for persistent pulmonary hypertension","volume":"160","author":"Vijlbrief","year":"2012","journal-title":"J Pediatr"},{"issue":"4","key":"10.1053\/j.semperi.2013.01.009_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/pr.2012.88","article-title":"Use of cardiac biomarkers in neonatology","volume":"72","author":"Vijlbrief","year":"2012","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1542\/peds.2004-0525","article-title":"Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn","volume":"114","author":"Reynolds","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00246-008-9258-4","article-title":"NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies","volume":"30","author":"Nir","year":"2009","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3345\/kjp.2010.53.6.688","article-title":"Pulmonary hypertension in infants with bronchopulmonary dysplasia","volume":"53","author":"Kim","year":"2010","journal-title":"Korean J Pediatr"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1183\/09031936.00160307","article-title":"Biomarkers in pulmonary hypertension","volume":"32","author":"Warwick","year":"2008","journal-title":"Eur Respir J"},{"issue":"1 Pt 1","key":"10.1053\/j.semperi.2013.01.009_bib42","first-page":"L110","article-title":"Functional and pathological effects of prolonged hyperoxia in neonatal mice","volume":"275","author":"Warner","year":"1998","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1203\/PDR.0b013e3181bab0c7","article-title":"Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension","volume":"66","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Res"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1152\/japplphysiol.00711.2011","article-title":"Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygen","volume":"111","author":"Lakshminrusimha","year":"2011","journal-title":"J Appl Physiol"},{"issue":"7","key":"10.1053\/j.semperi.2013.01.009_bib45","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0002-9149(03)00910-X","article-title":"Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension","volume":"92","author":"Ivy","year":"2003","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib46","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1378\/chest.10-0969","article-title":"Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: SUPER-2","volume":"140","author":"Rubin","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1053\/j.semperi.2013.01.009_bib47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1542\/peds.2005-0523","article-title":"Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study","volume":"117","author":"Baquero","year":"2006","journal-title":"Pediatrics"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.110.016667","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension","volume":"125","author":"Barst","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.semperi.2013.01.009_bib49","unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: FDA recommends against use of revatio in children with pulmonary hypertension. \u3008http:\/\/www.fda.gov\/Drugs\/DrugSafety\u3009; 2012 [updated 30.08.12]."},{"key":"10.1053\/j.semperi.2013.01.009_bib50","doi-asserted-by":"crossref","unstructured":"Abman S.H, Kinsella J.P, Rosenzweig E.B, et al. Implications of the FDA warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Am J Respir Crit Care Med 2013 [in press], PMID: 23220921","DOI":"10.1164\/rccm.201210-1928PP"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J Pediatr"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jp.2011.158","article-title":"Sildenafil therapy for bronchopulmonary dysplasia: not quite yet","volume":"32","author":"Farrow","year":"2012","journal-title":"J Perinatol"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib53","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semperi.2013.01.009_bib54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PCC.0b013e3181936aee","article-title":"Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn","volume":"10","author":"Lakshminrusimha","year":"2009","journal-title":"Pediatr Crit Care Med"},{"issue":"14","key":"10.1053\/j.semperi.2013.01.009_bib55","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"10.1053\/j.semperi.2013.01.009_bib56","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib58","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.semperi.2013.01.009_bib59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.semperi.2013.01.009_bib60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with idiopathic pulmonary arterial hypertension","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib61","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ppul.20238","article-title":"Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease","volume":"40","author":"Zaidi","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1053\/j.semperi.2013.01.009_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","volume":"160","author":"Doran","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"issue":"13","key":"10.1053\/j.semperi.2013.01.009_bib64","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1517\/14656560903164228","article-title":"Inhalative iloprost\u2014pharmacology and clinical application","volume":"10","author":"Ewert","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib66","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjcard.2006.09.119","article-title":"Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil","volume":"99","author":"Ivy","year":"2007","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1053\/j.semperi.2013.01.009_bib67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension","volume":"158","author":"Levy","year":"2011","journal-title":"J Pediatr"},{"issue":"11","key":"10.1053\/j.semperi.2013.01.009_bib68","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.amjcard.2012.07.037","article-title":"Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children","volume":"110","author":"Krishnan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semperi.2013.01.009_bib69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.med.59.110106.212434","article-title":"Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension","volume":"60","author":"Abman","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.semperi.2013.01.009_bib70","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"10.1053\/j.semperi.2013.01.009_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2362.2006.01681.x","article-title":"Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan","volume":"36","author":"Beghetti","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib72","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/hrt.2005.072314","article-title":"Response to bosentan in children with pulmonary hypertension","volume":"92","author":"Maiya","year":"2006","journal-title":"Heart"},{"issue":"5","key":"10.1053\/j.semperi.2013.01.009_bib73","first-page":"491","article-title":"Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia","volume":"58","author":"Rugolotto","year":"2006","journal-title":"Minerva Pediatr"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1203\/PDR.0b013e318179954c","article-title":"Safety experience with bosentan in 146 children 2\u201311 years old with pulmonary arterial hypertension: results from the European postmarketing surveillance program","volume":"64","author":"Beghetti","year":"2008","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1053\/j.semperi.2013.01.009_bib75","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.clp.2012.06.009","article-title":"Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia","volume":"39","author":"O'Reilly","year":"2012","journal-title":"Clin Perinatol"},{"issue":"11","key":"10.1053\/j.semperi.2013.01.009_bib76","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200902-0179OC","article-title":"Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats","volume":"180","author":"van Haaften","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1053\/j.semperi.2013.01.009_bib77","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1164\/rccm.200902-0242OC","article-title":"Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease","volume":"180","author":"Aslam","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1053\/j.semperi.2013.01.009_bib78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/2045-8932.97603","article-title":"Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension","volume":"2","author":"Hansmann","year":"2012","journal-title":"Pulm Circ"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000513000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000513000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T12:13:27Z","timestamp":1644754407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000513000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0146000513000104"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2013.01.009","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}